Xylitol is one of 129 small molecule programs targeting Sinusitis. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
386 competitors in Cystic Fibrosis
Xylitol
Onglyza
Calciferol
Vibramycin
Actimmune
Proair HFA
Aztreonam Lysine
Serevent
Amitiza
Capromorelin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details